HemaSphere (Jun 2022)

P969: COMPARISON OF VENOUS THROMBOEMBOLISM INCIDENCE IN MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE-BASED REGIMENS WITH RIVAROXABAN OR ASPIRIN THROMBOPROPHYLAXIS

  • Y. Wang,
  • X. Tang,
  • W. Zheng,
  • Z. Wang,
  • J. Xu,
  • X. Tan,
  • Y. Tian,
  • R. Xu,
  • S. Cui

DOI
https://doi.org/10.1097/01.HS9.0000846744.38970.75
Journal volume & issue
Vol. 6
pp. 859 – 860

Abstract

Read online

No abstracts available.